Question to the Department of Health and Social Care:

To ask His Majesty's Government whether ensuring that high-risk men get access to prostate cancer screening will be an objective of the national cancer plan.

Early diagnosis is a key focus of the National Cancer Plan, which will build on the shifts in care set out in the 10-Year Health Plan to diagnose cancers earlier. The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including prostate cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s survival rates.

My Rt Hon. Friend, the Secretary of State for Health and Social Care will consider the final recommendation of the UK National Screening Committee (UK NSC) on screening for prostate cancer when it is received. He will make a decision on whether to accept the recommendation, including any decisions on implementation at that point.

It is anticipated that the final recommendation will be provided in early 2026 after the conclusion of a 12-week consultation which opened on 28 November 2025. This seeks views on an evidence review and a draft recommendation to:

• offer a targeted national prostate cancer screening programme to men with confirmed BRCA1/2 gene variants every two years, from 45 years old to 61 years old;
• not recommend population screening;
• not recommend targeted screening of black men;
• not recommend targeted screening of men with family history; and
• collaborate with the Transform trial team to answer outstanding questions on screening effectiveness for black men and men with a family history as soon as the trial data becomes available, and to await the results of the study to develop and trial a more accurate test than the prostate specific antigen test alone, to improve the balance of benefit and harm of screening.